Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 55 Records) |
| Query Trace: Neoplasms and SPOP[original query] |
|---|
| Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland. International journal of cancer 2020 Sep . Woko?orczyk Dominika, Klu?niak Wojciech, Huzarski Tomasz, Gronwald Jacek, Szymiczek Agata, Rusak Bogna, Stempa Klaudia, Gliniewicz Katarzyna, Kashyap Aniruddh, Morawska Sylwia, D?bniak Tadeusz, Jakubowska Anna, Szwiec Marek, Domaga?a Pawe?, Lubi?ski Jan, Narod Steven A, Akbari Mohammad R, Cybulski Cezary, |
| Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer. European urology 2020 7 78 (5): 652-656. Swami Umang, Isaacsson Velho Pedro, Nussenzveig Roberto, Chipman Jonathan, Sacristan Santos Victor, Erickson Stephanie, Dharmaraj Divya, Alva Ajjai Shivaram, Vaishampayan Ulka N, Esther John, Hahn Andrew W, Maughan Benjamin Louis, Antonarakis Emmanuel S, Agarwal Neer |
| Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer. American journal of clinical oncology 2020 6 43 (10): 685-689. Lehrer Steven, Rheinstein Peter |
| Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer. Cancer genomics & proteomics 0 17 (3): 271-275. Lehrer Steven, Rheinstein Peter |
| Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer. Frontiers in genetics 2020 12 11 595657. Zhang Enchong, He Jieqian, Zhang Hui, Shan Liping, Wu Hongliang, Zhang Mo, Song Yongshe |
| Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis. Open medicine (Warsaw, Poland) 2020 12 15 (1): 1039-1047. Ding Guanxiong, Sun Jianliang, Jiang Lianhua, Gao Peng, Zhou Qidong, Wang Jianqing, Tong Shij |
| Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model. Frontiers in oncology 2020 12 10 598801. Zhang Yanlong, Zhang Ruiqiao, Liang Fangzhi, Zhang Liyun, Liang Xuez |
| TP53, SPOP and PIK3CA Genes Status in Prostate Cancer. Asian Pacific journal of cancer prevention : APJCP 2020 Nov 21 (11): 3365-3371. Al Zoubi Mazhar Salim, Otoum Raed, Alorjani Mohammed S, Al Bashir Samir, Al Trad Bahaa, Abualrja Manal Issam, Al-Khatib Sohaib M, Al-Batayneh Khal |
| NCOR1 may be a potential biomarker of a novel molecular subtype of prostate cancer. FEBS open bio 2020 Oct . Tang Lu, Zhang Lixia, Liu Lei, Dong Liping, Dong Yuan, Zhu Wenhe, Wang Huiy |
| The SPOP-ITCH Signaling Axis Protects Against Prostate Cancer Metastasis. Frontiers in oncology 2021 7 11 658230. Ma Jinlu, Cai Mengjiao, Mo Yaqi, Fried Joshua S, Tan Xinyue, Ma Yuan, Chen Jie, Han Suxia, Xu |
| Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 2 27 (9): 2613-2623. Momeni-Boroujeni Amir, Dahoud Wissam, Vanderbilt Chad M, Chiang Sarah, Murali Rajmohan, Rios-Doria Eric V, Alektiar Kaled M, Aghajanian Carol, Abu-Rustum Nadeem R, Ladanyi Marc, Ellenson Lora H, Weigelt Britta, Soslow Robert |
| Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer. Prostate cancer and prostatic diseases 2021 2 24 (3): 786-793. Armstrong Andrew J, Li Xiaotong, Tucker Matthew, Li Shantao, Mu Xinmeng Jasmine, Eng Kenneth Wha, Sboner Andrea, Rubin Mark, Gerstein Ma |
| Clinical and genomic features of SPOP-mutant prostate cancer. The Prostate 2021 Nov . Nakazawa Mari, Fang Mike, H Marshall Catherine, Lotan Tamara L, Isaacsson Velho Pedro, Antonarakis Emmanuel |
| Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions. Prostate cancer and prostatic diseases 2021 Jan . Chalmers Zachary R, Burns Michael C, Ebot Ericka M, Frampton Garrett M, Ross Jeffrey S, Hussain Maha H A, Abdulkadir Sarki |
| Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer. Frontiers in oncology 2022 12 957404. Zhou Jie, Lai Yiming, Peng Shengmeng, Tang Chen, Chen Yongming, Li Lingfeng, Huang Hai, Guo Zhengh |
| SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 9 28 (22): 4917-4925. Swami Umang, Graf Ryon P, Nussenzveig Roberto H, Fisher Virginia, Tukachinsky Hanna, Schrock Alexa B, Li Gerald, Ross Jeffrey S, Sayegh Nicolas, Tripathi Nishita, Mathew Thomas Vinay, Oxnard Geoffrey R, Antonarakis Emmanuel S, Agarwal Neer |
| Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers. Genome medicine 2022 Aug 14 (1): 100. Gong Tingting, Jaratlerdsiri Weerachai, Jiang Jue, Willet Cali, Chew Tracy, Patrick Sean M, Lyons Ruth J, Haynes Anne-Maree, Pasqualim Gabriela, Brum Ilma Simoni, Stricker Phillip D, Mutambirwa Shingai B A, Sadsad Rosemarie, Papenfuss Anthony T, Bornman Riana M S, Chan Eva K F, Hayes Vanessa |
| FLG Gene Mutation Up-regulates the Abnormal Tumor Immune Response and Promotes the Progression of Prostate Cancer. Current pharmaceutical biotechnology 2022 4 23 (14): 1658-1670. Zhang Peng, An Zesheng, Sun Changhai, Xu Yong, Zhang Zhiho |
| rs2671655 single nucleotide polymorphism modulates the risk for gastric cancer in Helicobacter pylori-infected individuals: a genome-wide association study in the Korean population. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2022 3 25 (3): 573-585. Shin Cheol Min, Park Kyungtaek, Kim Nayoung, Won Sungho, Ohn Jung Hun, Lee Sejoon, Park Ji Hyun, Kang Seung Joo, Kim Joo Sung, Lee Dong |
| Determination of ERG(+), EZH2, NKX3.1, and SPINK-1 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer. Cancer reports (Hoboken, N.J.) 2022 10 e1728. Segura-Moreno Yenifer Yamile, Sanabria-Salas María Carolina, Mesa-López De Mesa Jorge Andrés, Varela-Ramirez Rodolfo, Acosta-Vega Natalia Lizeth, Serrano Martha Luc |
| The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies. Frontiers in immunology 2022 10 13 1009634. Chen Lei, Zheng Yi, Jiang Changqin, Yang Cheng, Zhang Li, Liang Chaozh |
| Molecular features of prostate cancer post-neoadjuvant therapy in the Phase 3 CALGB 90203 trial. Journal of the National Cancer Institute 2023 9 . Takayuki Sumiyoshi, Xiaofei Wang, Evan W Warner, Andrea Sboner, Matti Annala, Michael Sigouros, Kevin Beja, Kei Mizuno, Shengyu Ku, Ladan Fazli, James Eastham, Mary-Ellen Taplin, Jeffrey Simko, Susan Halabi, Michael J Morris, Martin E Gleave, Alexander W Wyatt, Himisha Beltr |
| Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients. European journal of medical research 2023 7 28 (1): 239. Bin Lang, Chen Cao, Xiaoxiao Zhao, Yi Wang, Ying Cao, Xueying Zhou, Tong Zhao, Yuyan Wang, Ting Liu, Wenjia Liang, Zheng Hu, Xun Tian, Jingjing Zhang, Yongji Y |
| Clinical significance of SPOP and APC gene alterations in colorectal cancer in Indian population. Molecular genetics and genomics : MGG 2023 6 . Asgar Ali, Nimisha, Abhay Kumar Sharma, Pramod Kumar Mishra, Sundeep Singh Salu |
| Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. Anticancer research 2023 6 43 (7): 2941-2949. Christian Rocca, Giulia Rocca, Pietro Zampieri, Lucio Dell'atti, Nicoletta Bianchi, Carmelo Ippolito, Gianluca Aguia |
| Glycyl-tRNA Synthetase (GARS) Expression Is Associated with Prostate Cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro. International journal of molecular sciences 2023 3 24 (5): . Khosh Kish Ealia, Gamallat Yaser, Choudhry Muhammad, Ghosh Sunita, Seyedi Sima, Bismar Tarek |
| Determination of TMPRSS2-ERG, SPOP, FOXA1, and IDH1 prostate cancer molecular subtypes in Colombian patients and their possible implications for prognosis. Cell biology international 2023 2 . Montero-Ovalle Wendy, Sanabria-Salas María C, Mesa-López de Mesa Jorge, Varela-Ramírez Rodolfo, Segura-Moreno Yenifer Y, Sánchez-Villalobos Santiago A, Nuñez-Lemus Marcela, Serrano Martha |
| Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis. Urologic oncology 2023 10 . Mohammed Al-Toubat, Samuel Serrano, Ahmed Elshafei, Kashyap Koul, Allison H Feibus, K C Bala |
| The Mutational and Transcriptional Landscapes of Speckle-Type POZ Protein (SPOP) and Androgen Receptor (AR) in a Single-Center pT3 Prostatectomy Cohort. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2023 10 43 (1): 15-29. Isil Ezgi Eryilmaz, Berna Aytac Vuruskan, Onur Kaygisiz, Gulsah Cecener, Unal Egeli, Hakan Vurusk |
| Molecular features and race-associated outcomes of SPOP-mutant metastatic castration-resistant prostate cancer. The Prostate 2023 1 . Stangl Andrew, Wilner Christopher, Li Pin, Maahs Lucas, Hwang Clara, Pilling Aman |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: